Results 181 to 190 of about 32,363 (272)

Network Pharmacology-Guided Identification of <i>Candida albicans</i> Secondary Metabolites as Modulators of HIV Latency via Oncogenic Signaling Pathways. [PDF]

Int J Mol Sci
Oduro-Kwateng E, Anyaneji UJ, Fanele A, Ntanzi N, Soliman ME, Mkhwanazi NP.   +5 more
europepmc   +1 more source

Secreted factors induced by PKC modulators do not indirectly cause HIV latency reversal. [PDF]

Virology, 2023
Moran JA, Ranjan A, Hourani R, Kim JT, Wender PA, Zack JA, Marsden MD.   +6 more
europepmc   +1 more source

Nonclinical Considerations for Support of Pregnancy and Lactation in Clinical Trials

Birth Defects Research, Volume 118, Issue 6, June 2026.
ABSTRACT Background Pregnant and breastfeeding individuals remain underrepresented in clinical drug development, leaving health care providers and patients with limited data to inform treatment decisions. Current practice relies heavily on nonclinical developmental and reproductive toxicity (DART) studies in animals, while clinical trials typically ...
Dinesh Stanislaus, Christopher J. Bowman, Kimberly C. Brannen, Sarah N. Campion, Laura M. Carlson, Stephan Chalon, Anthony M. DeLise, Claudia Demarta‐Gatsi, Brian P. Enright, Wendy Halpern, Shermaine Mitchell‐Ryan, Vicki Sutherland, Karen Thacker, Kary Thompson, Belen Tornesi, Steven Van Cruchten, Ronald L. Wange, Tacey White, Connie L. Chen   +18 more
wiley   +1 more source

Viral latency in HIV disease

Cell, 1995
openaire   +2 more sources

Identification of inducible HIV reservoirs in tonsillar, intestinal and cervical tissue models of HIV latency. [PDF]

Nat Commun
Gallego-Cortés A, Sánchez-Gaona N, Mancebo-Pérez C, Ruiz-Isant O, Benítez-Martínez A, Landolfi S, Castellví J, Pumarola F, Ortiz N, Llano I, Lorente J, Mañalich-Barrachina L, Prado JG, Martín-Gayo E, Falcó V, Genescà M, Buzon MJ.   +16 more
europepmc   +1 more source

A Camptothetin Analog, Topotecan, Promotes HIV Latency via Interference with HIV Transcription and RNA Splicing. [PDF]

J Virol, 2023
Mukim A, Smith DM, Deshmukh S, Qazi AA, Beliakova-Bethell N.   +4 more
europepmc   +1 more source

Rapid Resolution of Grade VI Facial Nerve Paralysis in Ramsay Hunt Syndrome With Prompt Dual Antiviral‐Corticosteroid Therapy: A Case Report

Clinical Case Reports, Volume 14, Issue 6, June 2026.
ABSTRACT Ramsay Hunt syndrome, caused by varicella‐zoster virus reactivation, presents with facial paralysis, otalgia, and auricular vesicles. A Tanzanian woman with Grade VI facial palsy was treated with acyclovir and prednisolone, recovering to Grade II within 2 weeks.
Jacob Henry Kitundu, Kasimu Ally Juma, Kajiru Gad Kilonzo, Elichilia Robert Shao, Christine Leons Mmanda   +4 more
wiley   +1 more source

The effect of combining HIV latency reversal with inhibition of phosphoinositide-3 kinases or B-cell lymphoma-2 on the HIV reservoir. [PDF]

PLoS Pathog
Kim Y, Anderson JL, Tumpach C, Solomon A, Ong J, Tanaka K, Zerbato JM, Tan T, Teh CE, Gray DHD, Arandjelovic P, McMahon J, Meagher N, Price D, Pellegrini M, Roche M, Lewin SR.   +16 more
europepmc   +1 more source

PolyIC-coated Prussian blue nanoparticles as a dual-mode HIV latency reversing agent. [PDF]

Nanomedicine (Lond), 2022
Balakrishnan PB, Holmberg CS, Ledezma DK, Bosque A, Fernandes R.   +4 more
europepmc   +1 more source

Fibromyalgia in the Setting of Prior Epstein–Barr Virus Infection: A Case Report

Clinical Case Reports, Volume 14, Issue 6, June 2026.
ABSTRACT Accurate diagnosis of fibromyalgia requires careful consideration of overlapping conditions. This case underscores the role of Epstein–Barr virus (EBV) serology in patients with persistent fatigue and pain, while illustrating the challenges of diagnosing fibromyalgia amid concurrent health problems.
Saachi Bhattessa, Tirth Dave, Priti Modi
wiley   +1 more source